Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 10, 2003, Pages 1052-1059

  Ohnishi, Akiko ^a,b   Sawa, Hirofumi ^a   Tsuda, Masumi ^a   Sawamura, Yutaka ^b   Itoh, Tomoo ^c   Iwasaki, Yoshinobu ^b   Nagashima, Kazuo ^a,b  

^a Lab of Molec and Cell Pathology   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti OLIG2 antibody; Auxiliary diagnostic tool; Human gliomas; Immunohistochemistry; Olig1; Olig2; Quantitative RT PCR

Indexed keywords

PROTEIN; PROTEIN OLIG 1; PROTEIN OLIG 2; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CELL LINEAGE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0141922119     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.10.1052     Document Type: Article

References (27)

1. Bailey P, Cushing H. A classification of tumors of the glioma group. Philadelphia: Lippincott, 1926
2. Bigner D, McLendon R, Bruner J. Russell & Rubinstein's pathology of tumors of the nervous system. London: Arnold Publishers, 1998
3. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000;18:636-45
4. Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999;18:4144-52
5. Kitange GJ, Smith JS, Jenkins RB. Genetic alterations and chemotherapeutic response in human diffuse gliomas. Expert Rev Anticancer Ther 2001;1:595-605
6. Reifenberger G, Louis DN. Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003;62:111-26
7. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-79
8. Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000;48:825-30
9. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-45
10. Lu QR, Yuk D, Alberta JA, et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25:317-29
11. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-43
12. Lu QR, Sun T, Zhu Z, et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86
13. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002;109:61-73
14. Wegner M. Expression of transcription factors during oligodendroglial development. Microsc Res Tech 2001;52:746-52
15. Rowitch DH, Lu QR, Kessaris N, et al. An "oligarchy" rules neural development. Trends Neurosci 2002;25:417-22
16. Marie Y, Sanson M, Mokhtari K, et al. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 2001;358:298-300
17. Lu QR, Park JK, Noll E, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA 2001;98:10851-56
18. Bonifacino J, Dasso M, Harford J, et al. Current protocols in cell biology. New York: John Wiley & Sons, Inc., 2000:6.1.1-2.16
19. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68
20. Prayson RA, Abramovich CM. Glioneuronal tumor with neuropil-like islands. Hum Pathol 2000;31:1435-38
21. Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206
22. Burger PC. What is an oligodendroglioma? Brain Pathol 2002;12:257-59
23. Shoshan Y, Nishiyama A, Chang A, et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors. Proc Natl Acad Sci USA 1999;96:10361-66
24. Popko B, Pearl DK, Walker DM, et al. Molecular markers that identify human astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 2002;61:329-38
25. Funato N, Ohyama K, Kuroda T, et al. Basic helix-loop-helix transcription factor epicardin/capsulin/Pod-1 suppresses differentiation by negative regulation of transcription. J Biol Chem 2003;278:7486-93
26. Sussman CR, Davies JE, Miller RH. Extracellular and intracellular regulation of oligodendrocyte development: roles of Sonic hedgehog and expression of E proteins. Glia 2002;40:55-64
27. Ding H, Shannon P, Lau N, et al. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res 2003;63:1106-13